Douglas J. Schwartzentruber, M.D., F.A.C.S.
Associate Director of Clinical Affairs
Douglas J. Schwartzentruber is associate director of clinical affairs at the Indiana University Melvin and Bren Simon Cancer Center. A surgical oncologist and professor of surgery at the Indiana University School of Medicine, he is also system medical director for Indiana University Health’s statewide cancer services.
Dr. Schwartzentruber is a native of Goshen, Ind., and a graduate of Goshen College. He attended medical school and completed a general surgery residency at the IU School of Medicine. He completed an immunotherapy fellowship in 1988 and a surgical oncology fellowship in 1990 at the National Cancer Institute (NCI) and served as senior investigator in the Surgery Branch of the NCI for 13 years. From 2003 to 2011, Dr. Schwartzentruber served as medical director for the IU Health Goshen Center for Cancer Care.
Dr. Schwartzentruber’s research protocols span many areas of cancer research. Most notably, his research on the role of vaccines in the treatment of malignant melanoma has gained both national and international attention. He has lectured at local, regional, national and international medical and scientific conferences. He has published 12 book chapters and 80 scholarly articles in peer-reviewed journals. Dr. Schwartzentruber serves on the editorial boards for the Journal of Translational Medicine and Personalized Medicine in Oncology.
He has won national awards, including Alpha Omega Alpha membership, the E.B. Rinker Academic Fellowship and the MAP Reader’s Digest International Fellowship. Schwartzentruber was also named to TIME magazine's 2010 list of the "100 Most Influential People in the World."